Papers

5

Total Citations

53

H-Index

4

About

Tomasz J. Czernuszewicz is a leading researcher in preclinical imaging, specializing in the development of advanced ultrasound technologies for noninvasive disease assessment in rodent models. His work bridges the gap between clinical imaging tools and preclinical research, with major contributions to robotic shear wave elastography (SWE) and 3D ultrasound systems. Czernuszewicz pioneered a robotic SWE platform for noninvasive staging of liver disease in murine models, enabling longitudinal studies of fibrosis progression—a critical tool for drug developers. He also developed a novel preclinical ultrasound platform for widefield 3D imaging of rodents, which has garnered 18 citations for its impact on in vivo imaging. His validation studies combining ultrasound with bioluminescence and magnetic resonance imaging for orthotopic pancreatic tumors (12 citations) and his work on assessing polycystic kidney disease via robotic 3D ultrasound (5 citations) demonstrate his versatility. With over 50 total citations, Czernuszewicz’s innovations in robotic imaging systems and multimodal validation have advanced the accuracy and accessibility of preclinical imaging, making him a key figure in translational biomedical research.

Research Focus

Key Achievements

4
H-Index
5
Papers
53
Total Citations
11
Avg Citations/Paper
🏆 Most Cited Paper
A new preclinical ultrasound platform for widefield 3D imaging of rodents
18 citations · 2018
📈 Most Prolific Year: 2022 (2 Papers)
🤝 Key Collaborators: 34
🏛 Institutions: SonoVol (United States), North Carolina State University, University of North Carolina at Chapel Hill

Top Papers

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 15 days ago